89 related articles for article (PubMed ID: 24333837)
1. Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.
Matsuda K; Uruno A; Kogure N; Sugawara K; Shimada H; Nezu M; Saito-Ito T; Iki Y; Kudo M; Shimizu K; Sato I; Yoshikawa T; Satoh F; Ito R; Yokoyama A; Rainey WE; Saito-Hakoda A; Ito S; Sugawara A
Mol Cell Endocrinol; 2014 Mar; 383(1-2):60-8. PubMed ID: 24333837
[TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production.
Bassett MH; Suzuki T; Sasano H; White PC; Rainey WE
Mol Endocrinol; 2004 Feb; 18(2):279-90. PubMed ID: 14645496
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase.
Condon JC; Pezzi V; Drummond BM; Yin S; Rainey WE
Endocrinology; 2002 Sep; 143(9):3651-7. PubMed ID: 12193581
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by up-regulation of transcription of the CYP11B2 gene.
Yamashiro T; Kuge H; Zhang J; Honke K
J Biochem; 2010 Jul; 148(1):115-23. PubMed ID: 20413672
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure.
Suzuki D; Saito-Hakoda A; Ito R; Shimizu K; Parvin R; Shimada H; Noro E; Suzuki S; Fujiwara I; Kagechika H; Rainey WE; Kure S; Ito S; Yokoyama A; Sugawara A
PLoS One; 2017; 12(8):e0181055. PubMed ID: 28800627
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells.
Szekeres M; Turu G; Orient A; Szalai B; Süpeki K; Cserzo M; Várnai P; Hunyady L
Mol Cell Endocrinol; 2009 Apr; 302(2):244-53. PubMed ID: 19418629
[TBL] [Abstract][Full Text] [Related]
7. High glucose stimulates expression of aldosterone synthase (
Shimada H; Kogure N; Noro E; Kudo M; Sugawara K; Sato I; Shimizu K; Kobayashi M; Suzuki D; Parvin R; Saito-Ito T; Uruno A; Saito-Hakoda A; Rainey WE; Ito S; Yokoyama A; Sugawara A
FEBS Open Bio; 2017 Sep; 7(9):1410-1421. PubMed ID: 28904869
[TBL] [Abstract][Full Text] [Related]
8. D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-epsilon and calcium signaling.
Chang HW; Wu VC; Huang CY; Huang HY; Chen YM; Chu TS; Wu KD; Hsieh BS
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E622-9. PubMed ID: 18171914
[TBL] [Abstract][Full Text] [Related]
9. Stimulus-selective induction of the orphan nuclear receptor NGFIB underlies different influences of angiotensin II and potassium on the human adrenal gland zona glomerulosa-specific 3β-HSD isoform gene expression in adrenocortical H295R cells.
Yarimizu D; Doi M; Ota T; Okamura H
Endocr J; 2015; 62(9):765-76. PubMed ID: 26096451
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates p44/42 MAP kinase partly through PKCepsilon in H295R cells.
Lehoux JG; Lefebvre A
Mol Cell Endocrinol; 2007 Feb; 265-266():121-5. PubMed ID: 17215072
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members.
Nogueira EF; Rainey WE
Endocrinology; 2010 Mar; 151(3):1060-70. PubMed ID: 20097716
[TBL] [Abstract][Full Text] [Related]
12. Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases.
Pezzi V; Clyne CD; Ando S; Mathis JM; Rainey WE
Endocrinology; 1997 Feb; 138(2):835-8. PubMed ID: 9003023
[TBL] [Abstract][Full Text] [Related]
13. Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice.
Spyroglou A; Manolopoulou J; Wagner S; Bidlingmaier M; Reincke M; Beuschlein F
J Mol Endocrinol; 2009 May; 42(5):407-13. PubMed ID: 19221003
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Janke J; Clasen R; Unger T; Kintscher U
Circulation; 2004 May; 109(17):2054-7. PubMed ID: 15117841
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: possible involvement of bone morphogenetic protein-6 actions.
Otani H; Otsuka F; Inagaki K; Suzuki J; Miyoshi T; Kano Y; Goto J; Ogura T; Makino H
Endocrinology; 2008 Jun; 149(6):2816-25. PubMed ID: 18308844
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production.
Uruno A; Matsuda K; Noguchi N; Yoshikawa T; Kudo M; Satoh F; Rainey WE; Hui XG; Akahira J; Nakamura Y; Sasano H; Okamoto H; Ito S; Sugawara A
J Mol Endocrinol; 2011 Feb; 46(1):37-49. PubMed ID: 21106862
[TBL] [Abstract][Full Text] [Related]
17. Interacting influence of potassium and polychlorinated biphenyl on cortisol and aldosterone biosynthesis.
Li LA; Lin TC
Toxicol Appl Pharmacol; 2007 May; 220(3):252-61. PubMed ID: 17350062
[TBL] [Abstract][Full Text] [Related]
18. Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan.
Zhao Y; Zhao S; Kuge Y; Tamaki N
J Nucl Med; 2013 Aug; 54(8):1384-8. PubMed ID: 23833272
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adrenal aldosterone production by serine protease prostasin.
Ko T; Kakizoe Y; Wakida N; Hayata M; Uchimura K; Shiraishi N; Miyoshi T; Adachi M; Aritomi S; Konda T; Tomita K; Kitamura K
J Biomed Biotechnol; 2010; 2010():793843. PubMed ID: 20204133
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
